학술논문

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma
Document Type
Article
Source
In: Cancers. (Cancers, February 2023, 15(3))
Subject
Language
English
ISSN
20726694